DME MP Releases Schedule For College-Level Admission Round 2 Of NEET PG, NEET MDS admissions

Madhya Pradesh: The Director of Medical Education (DME MP) has released the schedule for college-level admission against stray vacancies in round 2 of NEET PG and NEET MDS courses.

The fresh registration can be carried out from 24.11.2023 to 27.11.2023 (till 11:59 PM). The process of registration will be carried out for 4 days. The publication of the revised state merit list of registered candidates & eligible candidates list will be done on 28-11-2023. The vacancies will be published on 28-11-2023. For the detailed seat matrix, the candidates need to keep a tab on the official website of DME.

Also Read:KNRUHS Opens Window For Exercising Web Options For Stray Vacancy Phase Of BSc Nursing, PBBSc Nursing admissions

The choice-filling process will be carried out only after the merit list is published. The choice-filling process can be carried out from 28-11-2023 to 29-11-2023 (till 11:59 PM Midnight). 2 days have been allotted for choice choice-filling process. Real-time College wise merit list of applicants 10 times the number of college vacancies on the portal. Online attendance at the institute by the candidates needs to be done on 30.11.2023 (10:00 am to 2:00 pm). The admission process as per attendance merit will be carried out on 30.11.2023 (3:00 pm to 7:00 pm). The admission process will be carried out for a single day.

The MD and MS admissions are based on NEET PG, and MDS admissions are based on NEET MDS across the state. The Director of Medical Education takes care of the NEET PG and NEET MDS counseling process in the state. The Department of Medical Education plays a pivotal role in developing medical and para-medical personnel to cater to the state's health needs. The directorate facilitates comprehensive medical and dental education via various medical, dental, and paramedical colleges in the state.

To view the notice, click on the link below –

https://medicaldialogues.in/pdf_upload/time-schedule-pg-clc-2-2023-225972.pdf

Also Read:NBE CPR Awareness Programme on December 6th, here are guidelines for all accredited hospitals


from Medical News, Health News Latest, Medical News Today - Medical Dialogues | https://ift.tt/a5OPyzS

Comments

Post a Comment

Popular posts from this blog

'Details sought include Third-party info, hence exempted under RTI Act': NMC on RTI query on Faculty Gap in Medical Colleges

Image
New Delhi:  Stating that the details sought under the RTI includes third-party information, the National Medical Commission (NMC) has refused to disclose the names of the medical colleges that fell short on faculty counts and other teaching infrastructure. Recently activist Dr. KV Babu filed an application under the Right to Information Act seeking the details of the notices issued by the NMC Undergraduate Medical Education Board (UGMEB) to the medical colleges for deficiencies in Clinical Material and staff during the period from 01/01/2023 to 30/04/2024. He also sought to know the details of the fine imposed or the action taken by the NMC UG Board from 01/01/2023 to 30/04/2024. In response, the Apex medical regulatory body in India has said that the concerned information includes third party information. "Since the information sought by you, includes third party information, hence the same is exempted for as per Section 8(1) (j) of the Right to Information Act, 2005," th...
Read more

Zasocitinib therapy highly efficacious for treatment of severe plaque psoriasis: JAMA

Image
A recent study published in the Journal of American Medical Association revealed that Zasocitinib could be a breakthrough in the treatment of moderate to severe plaque psoriasis. Psoriasis is a chronic inflammatory skin condition characterized by red, scaly patches, affects millions throughout the globe. While several treatments exist, the demand for new, effective, and well-tolerated oral therapies remains high. Zasocitinib, a highly selective allosteric tyrosine kinase 2 (TYK2) inhibitor, emerges as a promising candidate to meet this need. This trial was conducted between August 2021 and September 2022 across 55 centers in the US and Canada and found that Zasocitinib not only significantly improved skin clearance in patients but also expressed a favorable safety and tolerability profile. The study enrolled a total of 287 participants aged between 18 and 70 years, each with a Psoriasis Area and Severity Index (PASI) score of 12 or greater, a Physician’s Global Assessment score of 3...
Read more

New wearable laser device may monitor brain blood flow to gauge stroke risk, reports research

Image
Researchers have developed a laser-based device that can be placed on the head to non-invasively monitor changes in brain blood flow and volume. The new device could one day help save lives by offering a direct and simple way to assess stroke risk based on physiological markers rather than indirect markers like lifestyle factors. Strokes occur when blood flow to the brain is blocked or reduced, causing debilitating brain cell damage. With about 15 million people worldwide affected by strokes each year, it is the second leading cause of death and a leading cause of long-term disability. “The lack of a cost-effective and scalable stroke risk assessment system complicates long-term stroke prevention because a physician can’t tell whether a patient’s risk is stable or worsening,” said research team member Simon Mahler, a postdoctoral scholar in Changhuei Yang’s laboratory at the California Institute of Technology. “This new method could help catch early signs of increased stroke risk, w...
Read more